Protalix BioTherapeutics (PLX) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.66% |
| Dec 31, 2025 | -80.78% |
| Sep 30, 2025 | 20.28% |
| Jun 30, 2025 | 15.32% |
| Mar 31, 2025 | -34.93% |
| Dec 31, 2024 | 86.09% |
| Sep 30, 2024 | 23.81% |
| Jun 30, 2024 | 22.23% |
| Mar 31, 2024 | 8.75% |
| Dec 31, 2023 | -2.15% |
| Sep 30, 2023 | 19.03% |
| Jun 30, 2023 | 33.78% |
| Mar 31, 2023 | 15.43% |
| Dec 31, 2022 | 22.42% |
| Sep 30, 2022 | 20.79% |
| Jun 30, 2022 | -69.17% |
| Mar 31, 2022 | 47.83% |
| Dec 31, 2021 | -22.32% |
| Sep 30, 2021 | 10.45% |
| Jun 30, 2021 | -0.70% |
| Mar 31, 2021 | 7.38% |
| Dec 31, 2020 | 15.16% |
| Sep 30, 2020 | -3.58% |
| Jun 30, 2020 | 7.50% |
| Mar 31, 2020 | 17.34% |
| Mar 31, 2019 | 0.22% |
| Dec 31, 2018 | 21.15% |
| Sep 30, 2018 | 1.52% |
| Jun 30, 2018 | -4.36% |
| Mar 31, 2018 | -10.87% |
| Dec 31, 2017 | -6.14% |
| Sep 30, 2017 | -15.86% |
| Jun 30, 2017 | -45.82% |
| Mar 31, 2017 | -58.55% |
| Dec 31, 2016 | 22.86% |
| Sep 30, 2016 | 3.86% |
| Jun 30, 2016 | 4.54% |
| Mar 31, 2016 | -11.22% |
| Dec 31, 2015 | -7.81% |
| Sep 30, 2015 | -9.08% |
| Jun 30, 2015 | 9.24% |